Drug
Dinutuximab With Chemotherapy
Dinutuximab With Chemotherapy: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dinutuximab with Chemotherapy NCT05421897 | Phase 2 | Neuroblastoma |
Latest
No recent events.
Follow Dinutuximab With Chemotherapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.